Last updated: 07/03/2015, 7:53 AM UTC

Robert W. Baird Reaffirms Outperform Rating on Newlink Genetics Cor (NLNK) - Jags Report



Robert W. Baird Reaffirms Outperform Rating on Newlink Genetics Cor (NLNK)Jags ReportRobert W. Baird reissued their outperform rating on shares of Newlink Genetics Cor (NASDAQ: NLNK) in a report released on Monday. Robert W. Baird currently has a $20.00 target price on the stock. Separately, analysts at MLV Capital initiated coverage ...and more »…

Companies in this story

Companies in this story
  Comments

Be the first to comment on Robert W. Baird Reaffirms Outperform Rating on Newlink Genetics Cor (NLNK) - Jags Report

Disclaimer

Market data delayed 15 minutes.

This site is powered by PassFail. Ideas and opinions presented on this website are for informational and educational purposes only, and do not reflect the opinions of PassFail, or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice.

© 2015 Data provided by Morningstar® Read Full Disclaimer.
Data provided by Thomson Reuters. ©Thompson Reuters Limited. Click for restrictions.

IPO News